{"id":"https://openalex.org/W2576654980","doi":"https://doi.org/10.1021/acs.analchem.6b04726","title":"Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis","display_name":"Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis","alternate_titles":[],"publication_year":2017,"publication_date":"2017-01-25","ids":{"openalex":"https://openalex.org/W2576654980","doi":"https://doi.org/10.1021/acs.analchem.6b04726","mag":"2576654980","pmid":"https://pubmed.ncbi.nlm.nih.gov/28208257"},"language":"en","primary_location":{"id":"doi:10.1021/acs.analchem.6b04726","doi":"https://doi.org/10.1021/acs.analchem.6b04726","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.analchem.6b04726","pdf_url":null,"source":{"id":"https://openalex.org/S191963794","display_name":"Analytical Chemistry","issn_l":"0003-2700","issn":["0003-2700","1520-6882"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Analytical Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2576654980"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089605509","display_name":"Valentina D\u2019Atri","orcid":"https://orcid.org/0000-0002-2601-7092","observed_orcids":["https://orcid.org/0000-0002-2601-7092"]},"institutions":[{"id":"https://openalex.org/I114457229","display_name":"University of Geneva","ror":"https://ror.org/01swzsf04","country_code":"CH","type":"education","lineage":["https://openalex.org/I114457229"]},{"id":"https://openalex.org/I97565354","display_name":"University of Lausanne","ror":"https://ror.org/019whta54","country_code":"CH","type":"education","lineage":["https://openalex.org/I97565354"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Valentina D\u2019Atri","raw_affiliation_strings":["School\rof Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-2601-7092","affiliations":[{"raw_affiliation_string":"School\rof Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland","institution_ids":["https://openalex.org/I114457229","https://openalex.org/I97565354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073500738","display_name":"Szabolcs Fekete","orcid":"https://orcid.org/0000-0002-7357-0691","observed_orcids":["https://orcid.org/0000-0002-7357-0691"]},"institutions":[{"id":"https://openalex.org/I114457229","display_name":"University of Geneva","ror":"https://ror.org/01swzsf04","country_code":"CH","type":"education","lineage":["https://openalex.org/I114457229"]},{"id":"https://openalex.org/I97565354","display_name":"University of Lausanne","ror":"https://ror.org/019whta54","country_code":"CH","type":"education","lineage":["https://openalex.org/I97565354"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Szabolcs Fekete","raw_affiliation_strings":["School\rof Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School\rof Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland","institution_ids":["https://openalex.org/I114457229","https://openalex.org/I97565354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102929130","display_name":"Alain Beck","orcid":"https://orcid.org/0000-0002-4725-1777","observed_orcids":["https://orcid.org/0000-0002-4725-1777"]},"institutions":[{"id":"https://openalex.org/I4210135355","display_name":"Center of Immunology Pierre Fabre","ror":"https://ror.org/03gd99e09","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210135355","https://openalex.org/I4210143394"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alain Beck","raw_affiliation_strings":["Center of Immunology\rPierre Fabre, 5 Avenue Napol\u00e9on\rIII, BP 60497, Saint-Julien-en-Genevois, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Immunology\rPierre Fabre, 5 Avenue Napol\u00e9on\rIII, BP 60497, Saint-Julien-en-Genevois, France","institution_ids":["https://openalex.org/I4210135355"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024476955","display_name":"Matthew A. Lauber","orcid":"https://orcid.org/0000-0003-0929-903X","observed_orcids":["https://orcid.org/0000-0003-0929-903X"]},"institutions":[{"id":"https://openalex.org/I180980256","display_name":"Waters (United States)","ror":"https://ror.org/01h8xv021","country_code":"US","type":"company","lineage":["https://openalex.org/I180980256"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matthew Lauber","raw_affiliation_strings":["Waters Corporation, 34 Maple Street, Milford, Massachusetts 01757-3696, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Waters Corporation, 34 Maple Street, Milford, Massachusetts 01757-3696, United States","institution_ids":["https://openalex.org/I180980256"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001491891","display_name":"Davy Guillarme","orcid":"https://orcid.org/0000-0001-7883-5823","observed_orcids":["https://orcid.org/0000-0001-7883-5823"]},"institutions":[{"id":"https://openalex.org/I114457229","display_name":"University of Geneva","ror":"https://ror.org/01swzsf04","country_code":"CH","type":"education","lineage":["https://openalex.org/I114457229"]},{"id":"https://openalex.org/I97565354","display_name":"University of Lausanne","ror":"https://ror.org/019whta54","country_code":"CH","type":"education","lineage":["https://openalex.org/I97565354"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Davy Guillarme","raw_affiliation_strings":["School\rof Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School\rof Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland","institution_ids":["https://openalex.org/I114457229","https://openalex.org/I97565354"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5089605509"],"corresponding_institution_ids":["https://openalex.org/I114457229","https://openalex.org/I97565354"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":5.6297,"has_fulltext":false,"cited_by_count":103,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97196476,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"89","issue":"3","first_page":"2086","last_page":"2092"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.042100001126527786,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10683","display_name":"Mass Spectrometry Techniques and Applications","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hydrophilic-interaction-liquid-chromatography","display_name":"hydrophilic interaction liquid chromatography","score":0.9909999966621399},{"id":"https://openalex.org/keywords/therapeutic-monoclonal-antibodies","display_name":"therapeutic monoclonal antibodies","score":0.8830000162124634},{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9589999914169312},{"id":"https://openalex.org/keywords/glycosylation-profiling","display_name":"glycosylation profiling","score":0.878000020980835},{"id":"https://openalex.org/keywords/post-translational-modification","display_name":"post-translational modification","score":0.8420000076293945},{"id":"https://openalex.org/keywords/critical-quality-attributes","display_name":"critical quality attributes","score":0.8220000267028809},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.7720000147819519},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.8889999985694885},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.925000011920929},{"id":"https://openalex.org/keywords/quality-control","display_name":"quality control","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9058098793029785},{"id":"https://openalex.org/C116817701","wikidata":"https://www.wikidata.org/wiki/Q5955221","display_name":"Hydrophilic interaction chromatography","level":3,"score":0.8479107618331909},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.8376300930976868},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.6248326897621155},{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.5550958514213562},{"id":"https://openalex.org/C2777313579","wikidata":"https://www.wikidata.org/wiki/Q898365","display_name":"Glycosylation","level":2,"score":0.5311402678489685},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.4707772433757782},{"id":"https://openalex.org/C2781047461","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutical","level":2,"score":0.4530947804450989},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.44118601083755493},{"id":"https://openalex.org/C2780449318","wikidata":"https://www.wikidata.org/wiki/Q18344773","display_name":"Critical quality attributes","level":3,"score":0.43580514192581177},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.35800930857658386},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.2374279499053955},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1695723533630371},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08694618940353394},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002853","descriptor_name":"Chromatography, Liquid","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D006031","descriptor_name":"Glycosylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011134","descriptor_name":"Polysaccharides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011487","descriptor_name":"Protein Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011786","descriptor_name":"Quality Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D056148","descriptor_name":"Chromatography, Reverse-Phase","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D057927","descriptor_name":"Hydrophobic and Hydrophilic Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.analchem.6b04726","doi":"https://doi.org/10.1021/acs.analchem.6b04726","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.analchem.6b04726","pdf_url":null,"source":{"id":"https://openalex.org/S191963794","display_name":"Analytical Chemistry","issn_l":"0003-2700","issn":["0003-2700","1520-6882"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Analytical Chemistry","raw_type":"journal-article"},{"id":"pmid:28208257","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28208257","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Analytical chemistry","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.46810001134872437}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320924","display_name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","ror":"https://ror.org/00yjd3n13"},{"id":"https://openalex.org/F4320323830","display_name":"Universit\u00e9 de Gen\u00e8ve","ror":"https://ror.org/01swzsf04"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1883337067","https://openalex.org/W1976652440","https://openalex.org/W1977510035","https://openalex.org/W1982183807","https://openalex.org/W1995443607","https://openalex.org/W2004523879","https://openalex.org/W2006521244","https://openalex.org/W2015723482","https://openalex.org/W2017515622","https://openalex.org/W2023985105","https://openalex.org/W2035118667","https://openalex.org/W2036508874","https://openalex.org/W2051887366","https://openalex.org/W2052491267","https://openalex.org/W2056936283","https://openalex.org/W2057175703","https://openalex.org/W2059995755","https://openalex.org/W2060070314","https://openalex.org/W2068740108","https://openalex.org/W2074975150","https://openalex.org/W2091229935","https://openalex.org/W2094580354","https://openalex.org/W2103735104","https://openalex.org/W2110286249","https://openalex.org/W2117080495","https://openalex.org/W2136732030","https://openalex.org/W2140035322","https://openalex.org/W2155819450","https://openalex.org/W2157200718","https://openalex.org/W2175291039","https://openalex.org/W2177453654","https://openalex.org/W2324992833","https://openalex.org/W2325475319","https://openalex.org/W2326601291","https://openalex.org/W2328010630","https://openalex.org/W2342389091","https://openalex.org/W2343734409","https://openalex.org/W2410586475","https://openalex.org/W2466024678","https://openalex.org/W2498896723","https://openalex.org/W4235940105"],"related_works":["https://openalex.org/W2410586475","https://openalex.org/W3209141363","https://openalex.org/W4390549558","https://openalex.org/W4411355130","https://openalex.org/W4288176173","https://openalex.org/W2969353747","https://openalex.org/W4206364353","https://openalex.org/W1976736354","https://openalex.org/W2343734409","https://openalex.org/W2941544320"],"abstract_inverted_index":{"The":[0,43],"development":[1],"and":[2,23,27,39,58,68,78,114,120,153,173],"approval":[3],"processes":[4],"of":[5,32,46,81,90,104,131,137,144,171],"biosimilar":[6,38,174],"mAbs":[7,47,116,175],"depend":[8],"on":[9],"their":[10],"comparability":[11],"to":[12,19,50,133,148,156,161],"originators.":[13],"Therefore,":[14],"analytical":[15,60,166],"comparisons":[16],"are":[17],"required":[18],"assess":[20],"structural":[21],"features":[22,159],"post-translational":[24],"modifications":[25],"(PTM)":[26],"thereby":[28],"minimize":[29],"the":[30,88,101,108,129,141,169],"risk":[31],"being":[33],"clinically":[34],"meaningful":[35],"differences":[36],"between":[37],"originator":[40,113,172],"drug":[41],"products.":[42],"glycosylation":[44,71,105],"pattern":[45],"is":[48],"considered":[49],"be":[51,179],"an":[52],"important":[53],"critical":[54],"quality":[55,185],"attribute":[56],"(CQA),":[57],"several":[59],"approaches":[61],"have":[62],"been":[63],"proposed":[64],"that":[65,176],"facilitate":[66],"characterizing":[67],"monitoring":[69],"a":[70,76,124,164],"profile,":[72],"albeit":[73],"mainly":[74],"at":[75,107,140],"glycan":[77],"glycopeptide":[79],"level":[80,143],"analysis.":[82],"In":[83],"this":[84],"study,":[85],"we":[86],"demonstrate":[87,128],"utility":[89],"hydrophilic":[91,135],"interaction":[92],"chromatography":[93],"(HILIC)":[94],"hyphenated":[95],"with":[96],"mass":[97],"spectrometry":[98],"(MS)":[99],"for":[100,168,184],"qualitative":[102],"profiling":[103],"patterns":[106],"protein":[109,138],"level,":[110],"by":[111],"comparing":[112],"biosimilars":[115],"(Remicade/Remsina/Inflectra,":[117],"Herceptin/Trastuzumab":[118],"B,":[119],"Erbitux/Cetuximab":[121],"B)":[122],"using":[123],"middle-up":[125,142],"approach.":[126],"We":[127],"ability":[130],"HILIC":[132,158],"resolve":[134],"variants":[136],"biopharmaceuticals":[139],"analysis,":[145],"its":[146,154],"complementarity":[147],"reversed":[149],"phase":[150],"liquid":[151],"chromatography,":[152],"hyphenation":[155],"MS.":[157],"combined":[160],"MS":[162],"make":[163],"powerful":[165],"tool":[167],"comparison":[170],"could":[177],"eventually":[178],"applied":[180],"in":[181],"routine":[182],"analyses":[183],"control.":[186]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2576654980","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-01-26T00:00:00"}
